Singh BNImplantable cardioverter-defibrillators: Not the ultimate gold standard for gauging therapy of ventricular tachycardia and fibrillation?Am J Cardiol73:1211, 1994
2.
Zipes DPImplantable cardioverter-defibrillator: Life saver or a device looking for a disease?Circulation91:2115, 1994
3.
Kim SGImplantable defibrillator therapy: Does it really prolong life? How can we prove it?Am J Cardiol71:1213, 1993
4.
TheCardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary Report. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med321:406, 1989
5.
Cardiac Arrhythmia Suppression Trial II Investigators.Ethmozine exerts an adverse effect on mortality in survivors of acute myocardial infarction. N Engl J Med327:227, 1992
6.
Ahmed R., Singh BNAntiarrhythmic drugs. Curr Opin Cardiol8:10, 1993
7.
Singh BN, Ahmed R.Class III antiarrhythmic drugs. Curr Opin Cardiol19:12, 1993
8.
Siebels J., Cappato R., Ruppel R., Schneider R., Kuck KH, the CASH Investigators.Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol72:109F, 1993
9.
Wever EF, Hauer Rnw, Van Capelle Fjl et al. randomized study of implantable defibrillator as first-choice versus conventional strategy in postinfarct sudden death survivors. Circulation91:2195, 1995
10.
Singh B.Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy. Am J Cardiol72:114, 1993
11.
Connolly SJ , Yusuf S.Evaluations of the implantable cardioverter defibrillator in survivors of cardiac arrest: The need for randomized trials . Am J Cardiol69:959, 1992
12.
Mason JW, ESVEM Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med329:452, 1993
13.
Mason JW, ESVEM Investigators. A randomized comparison of electrophysiologic study to electrocardiographic monitoring for prediction of antiarrhythmic drug efficacy in patients with ventricular tachyarrhythmias. N Engl J Med329:445, 1993
14.
TheCASCADE Investigators. The Cascade Study: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol72:280, 1993
15.
Lathrop DA, Varro A., Nanasi PP, Bodi I., Takyi E., Pankucsi C.Differences in the effects of d- and dl-sotalol on isolated human ventricular muscle: Electromechanical activity after beta-adrenoceptor stimulationJ Cardiovasc Pharmacol Therapeut1:65, 1996
16.
Nademanee K. , Noll HE, Feld GKEffects of sotalol on His-Purkinje conduction and refractoriness in humans. J Cardiovasc Pharmacol Therapeut1:9, 1996
17.
Reiffel JAData driven decisions: The importance of clinical trials in arrhythmia management . J Cardiovasc Pharmacol Therapeut1:79, 1996
18.
Singh SN, Gross-Fisher S., Fletcher RD et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med33:77, 1995
19.
Holnloser S. , Klingenheben T., Singh BNAmiodarone-associated proarrhythmic effects: A review with special reference to torsades de pointes tachycardia. Ann Intern Med121:529, 1994
20.
Ziesche S., Rector TS, Cohn JNInterobserver discordance in the classification of mechanisms of death in studies of heart failure. J Cardiac Failure1:127, 1995
21.
Waldo AL, Camm AJ, de Ruyter H., Friedman PL, MacNeil DJ, Pitt B., Pratt CM, Schwartz PJ, Veltri EP, Sword Investigators.Preliminary mortality results from the Survival with Oral D-Sotalol (SWORD) trial. J Am Coll Cardiol15A, 1995
22.
Julian DG, Jackson FS, Prescott RJ, Szekely P.Control trial of sotalol for one year after myocardial infarction. Lancet1:1142, 1982
23.
Holmes J., Kubo S., Cody R., Kligfield P.Arrhythmias in ischemia and nonischemic dilated cardiomyopathy: Prediction of mortality by ambulatory electrocardiography. Am J Cardiol55:146, 1985
24.
Meinertz TE , Hoffman T., Kasper W. et al. Significance of ventricular arrhythmias in idiopathic cardiomyopathy. Am J Cardiol53:902, 1984
25.
Van Olshausen K, Schafer A., Mehmel HC et al. Ventricular arrhythmia in dilated cardiomyopathy . Br Heart J51:147, 1984
26.
Doval HC, Nul DR, Vancelli HO et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet344:493, 1994
27.
CIBIS Investigators and Committees.A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation90:1765, 1994
28.
Salerno D., Gillingam KJ, Berry DA, Hodges M.A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarization: A meta-analysis. Am Heart J120:340, 1990
